Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
    • Subscribe
Advertisement

Article

September 6, 2016

Music Therapy May Alleviate Psychological, Physical Symptoms Related to Cancer

Author(s):

Allie Casey

A recent review showed that music therapy helped ease symptoms in patients who were undergoing treatment for cancer.

Music interventions, which are a type of integrative therapy, can be used to soothe both psychological and physical symptoms, as well as treatment-related side effects for patients with cancer.

A recent review by researchers at Drexel University’s College of Nursing and Health Professions assessed the value of music interventions in the oncology setting. They examined 52 total studies involving 3,731 participants; 23 of the studies were classified as music therapy and 29 as music medicine interventions.

In an interview with Oncology Nursing News, Joke Bradt, Ph.D., M.T.-B.C., an associate professor at Drexel and lead researcher of this review, expanded on the distinction between the two interventions. Music medicine, she explained, involves a nurse offering patients in a study “pre-recorded music that will be just selected by the nurse” or the patient may be “given a list of options from which they can choose.”

Music therapy requires “a trained and board-certified music therapist who has been trained to use very specific individualized music interventions that are matching the patient’s in-the-moment needs.”

Importantly, music therapy doesn’t just consist of music listening. According to Bradt, the therapist first asks the patient about how they are feeling and then decides on any number of musical interventions going forward. “We might sing a song that helps the patient express some of the feelings, we might take out some percussion instruments and help the patient express nonverbally through playing instruments, or we might write a song with the patient about what they’re going through.”

Researchers found that music interventions had a moderate-to-strong effect in reducing anxiety. Findings from seven studies involving 723 participants pointed to a large treatment benefit in pain reduction, but the authors urged caution in interpreting this finding. Lesser effects were found in treating fatigue, reducing heart and respiratory rates and lowering blood pressure. While there were moderate increases in patient’s quality of life with music therapy, there were not similar effects in the case of music medicine intervention.

Study authors hypothesized that listening to music could reduce the need for anesthetics and analgesics, as well as decrease recovery time and duration of hospitalization. Bradt emphasized that although the review was not “a direct comparison between the two interventions,” she hopes that future studies will draw direct comparisons, so the “use of music on the continuum of cancer care” can be better understood.

Bradt also warned of the potential adverse effects of music intervention. “Music is not just this innocent, safe, nonintrusive intervention. Music can be quite intrusive.” According to Bradt, music can evoke strong emotions and memories that come with strong emotions, which could traumatize a patient. To counter this, it is important to have support services ready for the patient, to “check on the patients, and how they’re dealing emotionally.”

When choosing which patients may or may not benefit from which type of music intervention, one of the most important factors to consider is the patient’s relationship with music. If they strongly believe in the power of music, and of the therapeutic process, they would make a good candidate for either intervention. Someone who believes in music, but is hesitant about their musical abilities, might benefit more from music medicine intervention than music therapy.

And someone without much hope or with severely traumatic memories tied to music might be better off waiting to experience music interventions. Bradt clarified that sometimes, “those patients just need a little more time to build up a trust relationship with those therapists. When the time is provided they are able to open up, and often find music therapy very effective.”

Researchers hope that music interventions will become more widespread, and that healthcare providers, including the administrators who decide — as Bradt pointed out — “what kind of services are provided and reimbursed,” will be encouraged to seriously consider the use of music therapy in medical settings in the psychosocial care of people with cancer.

“These reviews show that music therapy and music [medicine] intervention is very effective for reducing anxiety, for helping with pain, helping with emotional distress. And those are important outcomes.”

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of two doctors and text.
Image of man.
Image of thumbnail.
Patients can prepare personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner in an interview with CURE.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
Image of woman.
Image of two people.
Image of doctor.
Image of woman.
Related Content
Advertisement
Image of Patti.
June 12th 2025

Beyond Treatment: How Support Groups Helped Me Embrace My New Normal

Patti McGee
Joining support groups after cancer treatment helped me heal emotionally, connect with others who understood and embrace a new, meaningful normal.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Graphic that reads "FDA APPROVED" resembling a stamp of approval
June 12th 2025

FDA Approves UGN-102 For Some With Bladder Cancer

Bridget Hoyt
The FDA has granted approval to UGN-102 for use in patients with low-grade intermediate-risk non-muscle-invasive bladder cancer.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Image of two doctors and text.
June 12th 2025

What Patients With Genitourinary Cancers Need to Know After ASCO 2025

Ryan Scott
Dr. Joshua K. Sabari and Dr. Daniel V. Araujo provide expert insights into genitourinary cancer updates from ASCO 2025.
FDA approves new Brukinsa tablet for five blood cancers: © stock.adobe.com.
June 12th 2025

FDA Approves Brukinsa Tablet For Various Blood Cancers

Spencer Feldman
FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as capsules.
Related Content
Advertisement
Image of Patti.
June 12th 2025

Beyond Treatment: How Support Groups Helped Me Embrace My New Normal

Patti McGee
Joining support groups after cancer treatment helped me heal emotionally, connect with others who understood and embrace a new, meaningful normal.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Graphic that reads "FDA APPROVED" resembling a stamp of approval
June 12th 2025

FDA Approves UGN-102 For Some With Bladder Cancer

Bridget Hoyt
The FDA has granted approval to UGN-102 for use in patients with low-grade intermediate-risk non-muscle-invasive bladder cancer.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Image of two doctors and text.
June 12th 2025

What Patients With Genitourinary Cancers Need to Know After ASCO 2025

Ryan Scott
Dr. Joshua K. Sabari and Dr. Daniel V. Araujo provide expert insights into genitourinary cancer updates from ASCO 2025.
FDA approves new Brukinsa tablet for five blood cancers: © stock.adobe.com.
June 12th 2025

FDA Approves Brukinsa Tablet For Various Blood Cancers

Spencer Feldman
FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as capsules.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.